NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Cash from Discontinued Operations (2019 - 2020)

Updated

NovaBridge Biosciences (NBP) posted Cash from Discontinued Operations of -$27.5 million for FY2024, compared with -$109.79 million in FY2023.

Analysis

NovaBridge Biosciences (NBP) Cash from Discontinued Operations (2019 - 2020) Analysis & Trends

Since FY2017, NovaBridge Biosciences has reported Cash from Discontinued Operations for 7 years.

  • The FY2024 figure stands as the highest annual Cash from Discontinued Operations in data going back to FY2017.
  • Business Quant data shows NBP's Cash from Discontinued Operations at -$109.79 million in FY2023, -$116.66 million in FY2022 and -$150.86 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -33.64 Mn
Dec 31, 2019 -30.64 Mn
API Access

NovaBridge Biosciences Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=NBP&period=max&api_key=YOUR_API_KEY